WallStreetZenWallStreetZen

NASDAQ: CMAX
CAREMAX INC Stock Forecast, Predictions & Price Target

Analyst price target for CMAX

Based on 2 analysts offering 12 month price targets for CAREMAX INC.
Min Forecast
$14.00+191.67%
Avg Forecast
$14.50+202.08%
Max Forecast
$15.00+212.5%

Should I buy or sell CMAX stock?

Based on 3 analysts offering ratings for CAREMAX INC.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

CMAX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Top 27%
74
Strong BuyInitiates Coverage On$15.00+212.50%2021-10-20
Piper Sandler
Bottom 10%
10
Strong BuyUpgradesN/AN/A2021-09-13
Cowen & Co.
Bottom 6%
6
BuyInitiates Coverage On$14.00+191.67%2021-09-10
Anonymous
Piper Sandler
HoldInitiates Coverage On$14.00+191.67%2021-07-01

1 of 1

Forecast return on equity

Is CMAX forecast to generate an efficient return?
Company
N/A
Industry
10.01%
Market
30.81%

Forecast return on assets

Is CMAX forecast to generate an efficient return on assets?
Company
N/A
Industry
7.03%

CMAX earnings per share forecast

What is CMAX's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.10
Avg 2 year Forecast
$0.26

CMAX revenue forecast

What is CMAX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$555.9M+37.34%
Avg 2 year Forecast
$733.0M+81.1%
Avg 3 year Forecast
$1.2B+208.04%
CMAX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CMAX revenue growth forecast

How is CMAX forecast to perform vs Health Information Services companies and vs the US market?
Company
40.72%
Industry
16.5%
Market
8.93%
CMAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CMAX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CMAX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
CMAX$4.80$14.50+202.08%Strong Buy
CNVY$5.76$14.60+153.47%Strong Buy
BBLN$0.96$9.70+910.42%Buy
OPRX$24.56$64.00+160.59%Strong Buy
ACCD$5.71$19.64+243.89%Buy

CAREMAX Stock Forecast FAQ

Is CAREMAX Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CMAX) stock is to Strong Buy CMAX stock.

Out of 3 analysts, 2 (66.67%) are recommending CMAX as a Strong Buy, 1 (33.33%) are recommending CMAX as a Buy, 0 (0%) are recommending CMAX as a Hold, 0 (0%) are recommending CMAX as a Sell, and 0 (0%) are recommending CMAX as a Strong Sell.

What is CMAX's earnings growth forecast for 2022-2023?

(NASDAQ: CMAX) CAREMAX's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 8.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.77%.

CAREMAX's earnings in 2022 is -$24,774,000.On average, 1 Wall Street analyst forecast CMAX's earnings for 2022 to be -$8,736,797, with the lowest CMAX earnings forecast at -$8,736,797, and the highest CMAX earnings forecast at -$8,736,797.

In 2023, CMAX is forecast to generate $22,715,673 in earnings, with the lowest earnings forecast at $22,715,673 and the highest earnings forecast at $22,715,673.

What is CMAX's revenue growth forecast for 2022-2024?

(NASDAQ: CMAX) CAREMAX's forecast annual revenue growth rate of 40.72% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 16.5%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.93%.

CAREMAX's revenue in 2022 is $404,765,000.On average, 2 Wall Street analysts forecast CMAX's revenue for 2022 to be $48,566,545,115, with the lowest CMAX revenue forecast at $48,381,761,854, and the highest CMAX revenue forecast at $48,751,328,376. On average, 3 Wall Street analysts forecast CMAX's revenue for 2023 to be $64,042,732,939, with the lowest CMAX revenue forecast at $60,417,573,677, and the highest CMAX revenue forecast at $68,786,551,715.

In 2024, CMAX is forecast to generate $108,932,134,849 in revenue, with the lowest revenue forecast at $108,932,134,849 and the highest revenue forecast at $108,932,134,849.

What is CMAX's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: CMAX) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 7.03%.

What is CMAX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CMAX price target, the average CMAX price target is $14.50, with the highest CMAX stock price forecast at $15.00 and the lowest CMAX stock price forecast at $14.00.

On average, Wall Street analysts predict that CAREMAX's share price could reach $14.50 by Oct 20, 2022. The average CAREMAX stock price prediction forecasts a potential upside of 202.08% from the current CMAX share price of $4.80.

What is CMAX's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: CMAX) CAREMAX's current Earnings Per Share (EPS) is -$0.07. On average, analysts forecast that CMAX's EPS will be -$0.10 for 2022, with the lowest EPS forecast at -$0.10, and the highest EPS forecast at -$0.10. In 2023, CMAX's EPS is forecast to hit $0.26 (min: $0.26, max: $0.26).

What is CMAX's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: CMAX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.